Literature DB >> 20610774

Prevalence of Staphylococcus aureus colonization in orthopaedic surgeons and their patients: a prospective cohort controlled study.

Ran Schwarzkopf1, Richelle C Takemoto, Igor Immerman, James D Slover, Joseph A Bosco.   

Abstract

BACKGROUND: Methicillin-resistant Staphylococcus aureus and methicillin-sensitive Staphylococcus aureus surgical site infections are an increasing health problem in the United States. To date, no study, as far as we know, has evaluated the prevalence of Staphylococcus aureus colonization in orthopaedic surgeons. The purpose of our study was to assess the prevalence of methicillin-resistant Staphylococcus aureus and methicillin-sensitive Staphylococcus aureus colonization in orthopaedic surgery attending surgeons and residents at our institution compared with that in our high-risk patients.
METHODS: We performed nasal swab cultures in seventy-four orthopaedic attending surgeons and sixty-one orthopaedic surgery residents at our institution, screening for methicillin-resistant Staphylococcus aureus and methicillin-sensitive Staphylococcus aureus. We compared these results with a prospective database of nasal cultures of patients undergoing joint replacement and spine surgery.
RESULTS: A total of 135 physicians were screened. Of those physicians, 1.5% were positive for methicillin-resistant Staphylococcus aureus and 35.7% were positive for methicillin-sensitive Staphylococcus aureus. None of the sixty-one residents were positive for methicillin-resistant Staphylococcus aureus. However, 59% were positive for methicillin-sensitive Staphylococcus aureus. Of the seventy-four attending surgeons, 2.7% were positive for methicillin-resistant Staphylococcus aureus and 23.3%, for methicillin-sensitive Staphylococcus aureus. Previous studies at our institution have demonstrated a 2.17% prevalence of nasal carriage of methicillin-resistant Staphylococcus aureus and an 18% rate of methicillin-sensitive Staphylococcus aureus in high-risk patients. Thus, no difference was found between the prevalence of methicillin-resistant Staphylococcus aureus in residents or attending surgeons and that in the high-risk patients. However, the prevalence of methicillin-sensitive Staphylococcus aureus colonization in the surgeons (35.7%) was significantly higher than that in the high-risk patient group (18%) (p < 0.01).
CONCLUSIONS: At a major teaching hospital, a higher prevalence of methicillin-sensitive Staphylococcus aureus colonization was found among attending and resident orthopaedic surgeons compared with a high-risk patient group, but the prevalence of methicillin-resistant Staphylococcus aureus colonization was similar.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20610774     DOI: 10.2106/JBJS.I.00991

Source DB:  PubMed          Journal:  J Bone Joint Surg Am        ISSN: 0021-9355            Impact factor:   5.284


  9 in total

1.  Impact of preoperative MRSA screening and decolonization on hospital-acquired MRSA burden.

Authors:  Sapna Mehta; Scott Hadley; Lorraine Hutzler; James Slover; Michael Phillips; Joseph A Bosco
Journal:  Clin Orthop Relat Res       Date:  2013-02-20       Impact factor: 4.176

2.  Biosynthesis of staphylococcal enterotoxin A by genetic engineering technology and determination of staphylococcal enterotoxin A in water by HPLC-ESI-TOF.

Authors:  Hong-Na Li; Fei Yuan; Yun-Jing Luo; Jian-Feng Wang; Chuan-Bin Zhang; Wei-E Zhou; Zhi-Qin Ren; Wen-Jie Wu; Feng Zhang
Journal:  Environ Sci Pollut Res Int       Date:  2017-07-04       Impact factor: 4.223

3.  Prevalence and population structure of Staphylococcus aureus nasal carriage in healthcare workers in a general population. The Tromsø Staph and Skin Study.

Authors:  K Olsen; M Sangvik; G S Simonsen; J U E Sollid; A Sundsfjord; I Thune; A-S Furberg
Journal:  Epidemiol Infect       Date:  2012-03-22       Impact factor: 2.451

4.  Staphylococcus aureus Decolonization Protocol Decreases Surgical Site Infections for Total Joint Replacement.

Authors:  Scott Hadley; Igor Immerman; Lorraine Hutzler; James Slover; Joseph Bosco
Journal:  Arthritis       Date:  2010-12-20

Review 5.  MRSA carriage among healthcare workers in non-outbreak settings in Europe and the United States: a systematic review.

Authors:  Madeleine Dulon; Claudia Peters; Anja Schablon; Albert Nienhaus
Journal:  BMC Infect Dis       Date:  2014-07-03       Impact factor: 3.090

6.  Relationship Between Staphylococcus aureus Carriage and Surgical Site Infections Following Total Hip and Knee Arthroplasty in the South Asian Population: Protocol for a Prospective Cohort Study.

Authors:  Syed H Mufarrih; Nada Q Qureshi; Anum Sadruddin; Pervaiz Hashmi; Syed Faisal Mahmood; Afia Zafar; Shahryar Noordin
Journal:  JMIR Res Protoc       Date:  2018-06-06

Review 7.  Role of healthcare apparel and other healthcare textiles in the transmission of pathogens: a review of the literature.

Authors:  A Mitchell; M Spencer; C Edmiston
Journal:  J Hosp Infect       Date:  2015-03-31       Impact factor: 3.926

8.  Antibiotic Resistance of Commensal Staphylococcus aureus and Coagulase-Negative Staphylococci in an International Cohort of Surgeons: A Prospective Point-Prevalence Study.

Authors:  Mario Morgenstern; Christoph Erichsen; Simon Hackl; Julia Mily; Matthias Militz; Jan Friederichs; Sven Hungerer; Volker Bühren; T Fintan Moriarty; Virginia Post; R Geoff Richards; Stephen L Kates
Journal:  PLoS One       Date:  2016-02-03       Impact factor: 3.240

9.  General Assembly, Prevention, Operating Room - Personnel: Proceedings of International Consensus on Orthopedic Infections.

Authors:  Andrea Baldini; Kier Blevins; Daniel Del Gaizo; Oliver Enke; Karan Goswami; William Griffin; Pier Francesco Indelli; Toby Jennison; Eustathios Kenanidis; Paul Manner; Robin Patel; Teija Puhto; Parag Sancheti; Rahul Sharma; Rajeev Sharma; Rjajendra Shetty; Rami Sorial; Naasha Talati; T David Tarity; Kevin Tetsworth; Christos Topalis; Eleftherios Tsiridis; Annette W-Dahl; Matthew Wilson
Journal:  J Arthroplasty       Date:  2018-10-22       Impact factor: 4.757

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.